Being told that you may have a blood cancer can raise many questions at once: What tests are needed? Which specialist should I see? Is a bone marrow test necessary? How is the exact type of blood cancer identified? And what treatment options might be available?

Blood cancer is not one single disease. It includes different cancers involving blood-forming tissues, bone marrow and the lymphatic system. Common groups include leukaemia, lymphoma and multiple myeloma, and each can require a different diagnostic and treatment approach.

The first step is usually to establish exactly what condition is present. Doctors may combine blood tests, imaging, pathology, bone marrow examination and specialised laboratory testing before deciding on treatment.

At Medicover Cancer Institute, Chintareddy Palem, Nellore, the published cancer-care information includes hemato-oncology, medical oncology, bone marrow transplantation, CAR-T cell therapy, nuclear medicine and multidisciplinary cancer care. The institute also lists CT, MRI and 4D PET-CT among its cancer diagnostic infrastructure.

This guide explains what patients can generally expect during the diagnosis and treatment process.

What Is Blood Cancer?

Blood cancers develop in cells involved in the production or function of blood and the immune system.

The major categories include:

Leukaemia

Leukaemia begins in blood-forming tissues such as the bone marrow and affects the production and development of blood cells.

There are different forms of leukaemia, including acute and chronic types. The exact subtype matters because treatment can differ considerably.

Lymphoma

Lymphoma develops in lymphocytes, a type of white blood cell involved in the immune system.

The two broad groups are:

• Hodgkin lymphoma
• Non-Hodgkin lymphoma

Within these groups are many different subtypes.

Multiple Myeloma

Multiple myeloma is a cancer of plasma cells, which are immune cells that normally produce antibodies.

Diagnosis and treatment require evaluation of blood, bone marrow and other clinical findings.

Because these diseases are so different, a diagnosis of "blood cancer" is only the beginning of the diagnostic process. Doctors generally need to establish the exact disease type, subtype and extent before selecting treatment.

What Are the Symptoms of Blood Cancer?

Symptoms vary depending on the specific disease and how it affects the body.

Possible symptoms can include:

• Persistent or unexplained fever
• Unusual tiredness or weakness
• Frequent infections
• Easy bruising or unusual bleeding
• Pale skin
• Unexplained weight loss
• Enlarged lymph nodes
• Night sweats
• Bone or joint discomfort
• Recurrent infections
• Shortness of breath
• Abdominal fullness or discomfort in some cases

These symptoms do not automatically mean that someone has blood cancer. Many common conditions can cause similar symptoms.

For example, fatigue may occur with anaemia, infections, nutritional deficiencies or many other medical conditions.

If symptoms are persistent, unusual or worsening, a doctor can determine whether further evaluation is appropriate.

What Is the First Test for Suspected Blood Cancer?

A doctor will generally begin with a clinical assessment and laboratory investigations based on the person's symptoms and medical history.

A complete blood count (CBC) is commonly important because it measures different types of blood cells, including:

• Red blood cells
• White blood cells
• Platelets
• Haemoglobin and related measurements

An abnormal blood count does not by itself establish a blood-cancer diagnosis.

Depending on the findings, doctors may recommend additional tests to understand why the blood counts are abnormal.

Other blood investigations can include tests evaluating:

• Kidney function
• Liver function
• Electrolytes
• Blood chemistry
• Clotting
• Other disease-specific markers

The exact combination depends on the clinical situation.

Which Tests Are Used to Diagnose Blood Cancer?

There is no single test that diagnoses every type of blood cancer.

Doctors may use several investigations to answer different questions.

1. Complete Blood Count

A CBC can identify abnormalities in blood-cell numbers.

For example, changes in white blood cells, red blood cells or platelets may prompt additional investigation.

However, an abnormal CBC can have many possible causes, so it should be interpreted in context.

2. Peripheral Blood Smear

A blood sample can sometimes be examined under a microscope to look at the appearance of blood cells.

A peripheral smear may provide additional information about abnormal or immature cells.

It is generally interpreted alongside the CBC and other clinical findings.

3. Bone Marrow Examination

A bone marrow aspiration and biopsy can be an important part of diagnosing certain blood cancers.

Bone marrow is where many blood cells are produced. Examining a sample can help doctors determine:

• Whether abnormal cells are present
• What type of abnormal cells are present
• How extensively the marrow is affected
• Whether additional specialised testing is needed

A bone marrow examination is not required in exactly the same way for every blood disorder or cancer. The decision depends on the suspected diagnosis and the information already available.

The Nellore Cancer Institute specifically lists hemato-oncology and a dedicated Bone Marrow Transplant unit among its cancer services.

Patients who have already undergone investigations elsewhere should bring their previous pathology reports, blood-test results and treatment records to the consultation.

What Is Flow Cytometry?

Flow cytometry is a laboratory technique that can analyse characteristics of individual cells.

In blood cancers, it can help identify and classify abnormal blood cells by examining markers on their surface or inside the cells.

It can be particularly useful when doctors are investigating certain forms of leukaemia or lymphoma.

The test may be performed using blood, bone marrow or other appropriate samples depending on the clinical situation.

Are Genetic or Molecular Tests Needed?

Sometimes.

Modern blood-cancer diagnosis can involve cytogenetic, molecular or other specialised laboratory testing.

These tests may help doctors:

• Classify the cancer more precisely
• Identify specific genetic or molecular abnormalities
• Understand disease characteristics
• Assess risk in certain diseases
• Help guide treatment selection
• Monitor disease in selected situations

Not every patient requires every molecular test.

The appropriate tests depend on the suspected cancer and the clinical question the treating team needs to answer.

This is particularly important because blood cancers that appear similar clinically may have different biological characteristics and therefore require different treatment strategies.

Is Imaging Used for Blood Cancer?

Yes, depending on the type of blood cancer and what doctors need to evaluate.

Imaging can help assess:

• Enlarged lymph nodes
• Involvement of organs or tissues
• Disease distribution
• Bone involvement
• Treatment response
• Other possible causes of symptoms

Potential imaging investigations can include:

• CT
• MRI
• PET-CT
• Other nuclear medicine examinations

Medicover Cancer Institute, Nellore lists CT, MRI, nuclear medicine and 4D PET-CT among its cancer diagnostic infrastructure.

The choice of imaging depends on the suspected diagnosis. A PET-CT, for example, is not automatically required for every person with a blood cancer.

You can learn more about the role of nuclear medicine through the institute's Nuclear Medicine service page.

How Is Blood Cancer Staged?

The concept of staging differs between blood cancers.

For some lymphomas, staging helps describe how extensively the disease has spread through the lymphatic system and other parts of the body.

For leukaemia, doctors may focus more heavily on the specific subtype, blood and bone marrow findings, genetic characteristics, risk factors and response to treatment rather than using the same staging system applied to many solid tumours.

Multiple myeloma also uses disease-specific classification and risk assessment.

Therefore, patients should not assume that every blood cancer is described using a simple Stage 1–4 system.

The diagnostic information is combined to create a more complete picture of the disease.

Which Specialist Treats Blood Cancer?

A haematologist or hemato-oncologist is generally involved in the diagnosis and treatment of blood cancers.

Depending on the disease and treatment plan, other specialists may also become involved.

Hemato-Oncologist

A hemato-oncologist specialises in blood disorders and blood cancers.

They may evaluate conditions such as:

• Leukaemia
• Lymphoma
• Multiple myeloma
• Other blood-related malignancies

Medical Oncologist

A medical oncologist manages cancer using systemic treatments such as chemotherapy, targeted therapy, immunotherapy and other medicines when appropriate.

The Medical Oncology department at Medicover Cancer Institute, Nellore lists chemotherapy, immunotherapy, targeted therapy, hormone therapy and biological therapy among its medical-oncology approaches.

Radiation Oncologist

Radiation oncology may have a role in selected blood cancers, particularly when a specific area requires radiation treatment.

The institute lists radiation oncology and techniques including IMRT, IGRT, VMAT, adaptive radiotherapy and brachytherapy.

Its Radiation Oncology department provides further information about its radiation-care services.

Pathologist

Pathologists examine blood, bone marrow, tissue and other samples to help establish and classify disease.

Pathology can involve techniques such as:

• Histopathology
• Cytology
• Immunohistochemistry
• Haematology testing
• Molecular diagnostics

The final diagnosis often depends on integrating pathology findings with clinical information and imaging rather than relying on one report alone.

Nuclear Medicine Specialist

Nuclear medicine specialists may be involved when PET-CT or other nuclear medicine investigations are needed.

How Is Blood Cancer Treatment Decided?

Treatment depends on the specific blood cancer, subtype, disease characteristics, extent of disease, previous treatment, overall health and other clinical factors.

There is no single treatment plan that applies to everyone.

Depending on the diagnosis, treatment may include one or more of the following.

Chemotherapy

Chemotherapy uses medicines designed to destroy or control cancer cells.

It remains an important treatment for several blood cancers, although the specific drugs, combinations and schedules differ considerably between diseases.

Targeted Therapy

Targeted therapies are designed to act on particular biological characteristics associated with cancer cells.

They may be considered when testing identifies a relevant target.

Targeted therapy is therefore not automatically suitable for every blood cancer.

Immunotherapy

Immunotherapy uses the body's immune system or modifies immune responses to help fight cancer.

Different forms of immunotherapy are used for different diseases.

The decision depends on the cancer type, disease characteristics, previous treatment and other factors.

Radiation Therapy

Radiation therapy may be appropriate in selected blood-cancer situations.

Its role depends on the type and distribution of disease and the purpose of treatment.

Stem Cell or Bone Marrow Transplantation

Some patients with blood cancers may be evaluated for a hematopoietic stem cell transplant, commonly called a bone marrow transplant.

It may be considered in selected situations depending on:

• Cancer type
• Disease risk
• Response to previous treatment
• Whether the disease has returned
• Overall health
• Donor availability and compatibility
• Other clinical factors

Medicover Cancer Institute, Nellore lists a dedicated BMT unit with autologous, allogeneic and haploidentical transplantation approaches.

Its Bone Marrow Transplant service explains that transplant evaluation can involve disease-response assessment, HLA typing, infection screening and organ-function evaluation when clinically required.

Importantly, being referred to a transplant specialist does not automatically mean that a transplant will be recommended.

What Is CAR-T Cell Therapy?

CAR-T cell therapy is an advanced cellular immunotherapy used for selected blood cancers.

It involves collecting a patient's T cells, modifying them so they can recognise particular cancer-cell targets, expanding the cells and administering them back to the patient.

Eligibility is highly specific.

It can depend on:

• Type of blood cancer
• Specific target on the cancer cells
• Previous treatments
• Response or recurrence
• Overall health
• Applicable treatment indications

Medicover Cancer Institute, Nellore lists CAR-T cell therapy among its cancer treatment services.

SirisHealthcare also provides information about CAR-T cell therapy for blood cancer, including the need for specialist assessment before determining eligibility.

Because CAR-T treatment can involve significant risks and specialised monitoring, suitability must be determined by an appropriately qualified specialist.

Why Does the Exact Blood Cancer Diagnosis Matter?

Two people can both be told that they have "blood cancer" but require completely different treatment approaches.

For example, treatment planning can change according to:

• Leukaemia versus lymphoma versus myeloma
• Specific subtype
• Genetic or molecular findings
• Disease risk
• Extent of disease
• Previous treatment
• Response to treatment
• Age and general health
• Organ function
• Treatment goals

This is why obtaining the correct diagnosis is such an important part of cancer care.

A treatment should not be selected simply because it was effective for another person with a different type of blood cancer.

What Should You Take to Your First Blood Cancer Consultation?

If you are travelling to another cancer centre for an initial consultation or second opinion, organise your medical records before the appointment.

Useful documents may include:

Diagnostic records

• CBC and other blood-test reports
• Bone marrow reports
• Biopsy reports
• Histopathology reports
• Immunohistochemistry reports
• Flow-cytometry results
• Molecular or genetic reports

Imaging

• CT reports
• MRI reports
• PET-CT reports
• Imaging files where available

Treatment history

• Previous chemotherapy records
• Radiation treatment summaries
• Transplant-related records
• Medication list
• Discharge summaries
• Previous specialist consultation notes

Personal medical information

Also provide information about:

• Current medicines
• Drug allergies
• Previous significant reactions
• Other major medical conditions
• Previous surgeries

For people travelling from another country, sending relevant records to the hospital before travelling, when the hospital permits this, may help the treating team understand the case and advise what additional information is required.

Do not assume that a remote review can replace an in-person clinical assessment when examination or additional testing is necessary.

What Happens After the Diagnosis?

Once the diagnostic information is available, the oncology team can discuss the findings and treatment options.

Depending on the case, the process may involve:

Initial assessment → Diagnostic testing → Disease classification → Staging/risk assessment → Specialist review → Treatment planning → Treatment → Response assessment → Follow-up

For complex cases, more than one specialist may contribute to the treatment plan.

Medicover Cancer Institute, Nellore describes a multidisciplinary approach involving medical, surgical and radiation oncology, with hemato-oncology and other specialist services available within the cancer-care structure.

This can be particularly relevant when a patient may require systemic therapy, transplant, radiation or other specialised treatment.

Can Patients Get a Second Opinion for Blood Cancer?

Yes. A second opinion can be useful when a patient wants another qualified specialist to review:

• The diagnosis
• Pathology results
• Disease classification
• Treatment recommendations
• Need for additional tests
• Transplant eligibility
• Possible treatment alternatives

A second opinion should be based on the complete medical record whenever possible.

SirisHealthcare also has a guide explaining which pathology reports, scans and treatment records to prepare for a cancer second opinion.

For a complex blood cancer, the quality and completeness of the available diagnostic information can be particularly important.

Blood Cancer Treatment in India: What Should Patients Consider?

Patients researching treatment in India should look beyond the name of a hospital or a single treatment.

Important questions include:

• Does the centre have the relevant oncology specialty?
• Is hemato-oncology available?
• What diagnostic tests are available?
• Can previous pathology and imaging be reviewed?
• Are transplant services available if they become clinically relevant?
• Is multidisciplinary cancer care available?
• What supportive-care services are provided?
• How will follow-up be coordinated?
• What records should be provided before travelling?
• Who should be contacted if additional information is needed?

For international patients, practical planning is also important. Medical records, pathology material, imaging files, medication information and treatment history should be organised before travel.

The treatment decision itself, however, should remain based on the individual's medical assessment rather than location alone.

Blood Cancer Diagnosis and Treatment at Medicover Cancer Institute, Nellore

Medicover Cancer Institute, Chintareddy Palem, Nellore, is described by SirisHealthcare as a dedicated cancer facility providing medical oncology, surgical oncology, radiation oncology and hemato-oncology services. The hospital page also lists pediatric oncology, breast oncology, thoracic oncology, bone marrow transplantation, nuclear medicine, palliative care, physiotherapy and rehabilitation.

For blood-cancer care specifically, the relevant services include hemato-oncology, bone marrow transplantation and CAR-T cell therapy, alongside diagnostic and supportive infrastructure.

Patients considering consultation can explore the Medicover Cancer Institute hospital profile for current hospital, specialty and appointment information.

The appropriate specialist and treatment pathway should always be determined after reviewing the patient's diagnosis, test results, medical history and overall health.

A Practical Checklist for Patients

If you or a family member has been diagnosed with or is being evaluated for blood cancer, consider preparing:

Before consultation

• ☐ Blood-test reports
• ☐ Bone marrow reports, if performed
• ☐ Biopsy/pathology reports
• ☐ Flow-cytometry results
• ☐ Molecular/genetic reports
• ☐ CT/MRI/PET-CT reports
• ☐ Imaging files
• ☐ Previous treatment records
• ☐ Current medication list
• ☐ Allergy information
• ☐ Previous discharge summaries
• ☐ Questions for the oncology team

During consultation

Ask:

1. What exact type of blood cancer is present?
2. What subtype is it?
3. Are additional tests needed?
4. Is bone marrow testing required?
5. Are molecular or genetic tests relevant?
6. What does the staging or risk assessment show?
7. Which specialist will coordinate treatment?
8. What treatment options are available?
9. Could transplant or cellular therapy be relevant?
10. How will treatment response be monitored?

Having these questions prepared can make a complex consultation easier to follow.

Conclusion

Blood cancer diagnosis is a step-by-step process rather than a single test.

Blood counts may provide the initial clue, but doctors may need blood-smear examination, bone marrow testing, pathology, flow cytometry, molecular studies and imaging to determine the precise disease. The appropriate combination depends on the suspected cancer and the individual patient's clinical findings.

Treatment is similarly individualised. Depending on the diagnosis, options can include chemotherapy, targeted therapy, immunotherapy, radiation therapy, stem-cell transplantation or advanced cellular therapies such as CAR-T treatment.

For patients researching care in India or considering a second opinion, the most useful first step is to organise the complete medical record and consult an appropriately qualified haematologist, hemato-oncologist or oncology team.

7. FAQs

1. What blood tests can detect blood cancer?

A complete blood count and other blood investigations can identify abnormalities that may require further evaluation. However, blood tests alone do not diagnose every type of blood cancer. Additional testing, such as blood-smear examination, flow cytometry, bone marrow examination, pathology or molecular testing, may be required depending on the suspected disease.

2. Is a bone marrow biopsy always required for blood cancer?

No. The need for a bone marrow examination depends on the suspected cancer and the information already available. It can be important for diagnosing or classifying certain blood cancers and assessing the bone marrow.

3. Which doctor treats blood cancer?

A haematologist or hemato-oncologist generally manages blood cancers. Depending on the diagnosis, a medical oncologist, radiation oncologist, transplant specialist, pathologist and other specialists may also participate in care.

4. Can blood cancer be treated with chemotherapy?

Chemotherapy is an important treatment for several blood cancers, but it is not the only possible treatment. Depending on the disease, treatment may also involve targeted therapy, immunotherapy, radiation therapy, stem-cell transplantation or other approaches.

5. When might a bone marrow transplant be considered?

A stem-cell or bone marrow transplant may be considered for selected patients depending on the type and risk of blood cancer, treatment response, previous treatment, overall health and other clinical factors. A transplant consultation does not automatically mean transplantation will be recommended.

6. Is CAR-T therapy suitable for every blood-cancer patient?

No. CAR-T cell therapy is used for selected blood cancers and specific clinical circumstances. Eligibility depends on factors such as the cancer type, target characteristics, previous treatment and overall health. A specialist must determine whether it is appropriate.

7. Can I seek a second opinion for blood cancer?

Yes. A second opinion can help clarify the diagnosis, disease classification, additional testing and treatment options. Patients should provide pathology reports, imaging, blood tests and previous treatment records so the reviewing specialist has the relevant information.

8. What should I bring if I am travelling to India for a blood-cancer consultation?

Bring or securely share your pathology and biopsy reports, blood-test results, bone marrow reports if available, imaging reports and files, previous treatment summaries, medication list and relevant medical history. Confirm with the hospital beforehand which documents and file formats they require.

8. Medical Disclaimer

Medical Disclaimer: This article is provided for general educational and informational purposes only. It does not replace professional medical consultation, diagnosis or treatment. Blood cancers include different diseases, and the appropriate diagnostic tests and treatment vary considerably between patients. The availability and suitability of a particular investigation, medicine, transplant or cellular therapy must be determined by a qualified healthcare professional after reviewing the patient's individual clinical information. If you have symptoms, an abnormal test result or a cancer diagnosis, consult an appropriately qualified medical or oncology specialist.